Valuation (57%) |
Company | Industry |
|---|---|---|
| P/E Ratio (TTM) | 34.44 | N/A |
| PEG Ratio (TTM) | -1.28 | N/A |
| P/S Ratio (TTM) | 2.12 | N/A |
| P/B Ratio (TTM) | 1.18 | N/A |
| P/FCF Ratio (TTM) | 66.17 | N/A |
| Price to 5YR AVG Earnings Ratio | 14.59 | N/A |
| Price to 5YR AVG FCF Ratio | 10.85 | N/A |
Profitability (18%) |
Company | Industry |
|---|---|---|
| ROA (TTM) | 0.80% | N/A |
| ROE (TTM) | 3.42% | N/A |
| Net Profit Margin (TTM) | 6.18% | N/A |
| ROIC 5YR AVG | 1.89% | N/A |
Growth (75%) |
4QTR AVG | 3YR AVG | 5YR AVG |
|---|---|---|---|
| EPS | 181.92% | 43.55% | 11.47% |
| Revenue | 6.78% | 7.53% | 4.07% |
| Net Income | 180.61% | 40.78% | 9.68% |
| Cash Flow | -69.57% | 45.86% | 25.28% |
Health (51%) |
Company | Industry |
|---|---|---|
| Current Ratio (TTM) | 20.94 | N/A |
| Quick Ratio (TTM) | 20.94 | N/A |
| D/E Ratio (TTM) | 2.68 | N/A |
| Interest Coverage (TTM) | 0.83 | N/A |
| Piotroski F-Score | 6 | N/A |
| Altman Z-Score | 2.54 | N/A |
| LTL to 5YR AVG FCF | 32.72 | N/A |
| Shares Outstanding Growth 5YR AVG | -1.53% | N/A |